Table 1 Baseline participant demographics

Age

51–83

Category

n

%

Sex

Female

6

60

Male

4

40

Income

(thousands)

< 20

1

10

40–59.9

2

20

60–79.9

1

10

> 80

5

50

Not specified

1

10

Education

Some high school

1

10

Completed high school

1

10

Some university/college

3

30

Completed university/college

3

30

Some graduate school

2

20

Marital Status

Married/common Law

8

80

Divorced/separated

1

10

Widowed

1

10

Employment Status

Retired

6

60

Disability/sick leave

4

40

Cancer Staging

Stage IV

10

100

Tumour Marker

PD-L1 High

6

60

EGFR activating mutation +

5

50

ALK translocation +

1

10

Treatment

Tyrosine Kinase Inhibitor

6

60

Immune Checkpoint Inhibitor

2

20

Immune Checkpoint Inhibitor + Chemotherapy

1

10

None

1

10

Treatment Duration

0–3 months

5

50

3–6 months

2

20

> 6 months

2

20

N/A

1

10